The effects of dutasteride, tamsulosin, and the combination on storage and voiding in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the Combination of Avodart and Tamsulosin study
- 1 September 2009
- journal article
- research article
- Published by Springer Nature in Prostate Cancer and Prostatic Diseases
- Vol. 12 (4) , 369-374
Abstract
This article reports the results of a post hoc analysis of the multicenter, randomized, double-blind Combination of Avodart and Tamsulosin (CombAT) study, which aimed to investigate the effects of dutasteride (0.5 mg), tamsulosin (0.4 mg), and their combination on storage and voiding symptoms in 4844 men aged 50 years with moderate-to-severe lower urinary tract symptoms (International Prostate Symptom Score 12), prostate volume (PV) 30 cm3 and PSA 1.5–10 ng ml−1. After 24 months, combination treatment achieved significantly greater mean reductions in both voiding and storage symptoms than either monotherapy, in each of the three baseline PV tertiles (30 to 3). Dutasteride was as effective as tamsulosin for control of storage symptoms, but provided significantly greater relief of voiding symptoms than tamsulosin.Keywords
This publication has 22 references indexed in Scilit:
- The Effects of Dutasteride, Tamsulosin and Combination Therapy on Lower Urinary Tract Symptoms in Men With Benign Prostatic Hyperplasia and Prostatic Enlargement: 2-Year Results From the CombAT StudyJournal of Urology, 2008
- Muscarinic receptor antagonists for overactive bladderBJU International, 2007
- 5?-reductase inhibition for men with enlarged prostateJournal of the American Academy of Nurse Practitioners, 2007
- A practical guide to the evaluation and treatment of male lower urinary tract symptoms in the primary care settingInternational Journal Of Clinical Practice, 2007
- Managing the progression of lower urinary tract symptoms/benign prostatic hyperplasia: therapeutic options for the man at riskBJU International, 2007
- Population-Based Survey of Urinary Incontinence, Overactive Bladder, and Other Lower Urinary Tract Symptoms in Five Countries: Results of the EPIC StudyEuropean Urology, 2006
- Management of Benign Prostate Hyperplasia: An Overview of α-Adrenergic AntagonistBiological and Pharmaceutical Bulletin, 2006
- The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence SocietyUrology, 2003
- Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasiaUrology, 2002
- α-BLOCKADE IMPROVES SYMPTOMS SUGGESTIVE OF BLADDER OUTLET OBSTRUCTION BUT FAILS TO RELIEVE ITJournal of Urology, 2001